Review

Published on 02 Sep 2024

The role of cytokines in the pathogenesis of SAPHO syndrome

in Cytokines and Soluble Mediators in Immunity

Yi Yang
Qianzhu Chen
Weiyang Zhong

Frontiers in Immunology

doi 10.3389/fimmu.2024.1427784

867 views

Review

Published on 30 Aug 2024

Rewiring the T cell-suppressive cytokine landscape of the tumor microenvironment: a new frontier for precision anti-cancer therapy

in Cytokines and Soluble Mediators in Immunity

Ludovica Lopresti
Vanessa Tatangelo
Cosima T. Baldari
Laura Patrussi

Frontiers in Immunology

doi 10.3389/fimmu.2024.1418527

1,047 views

Original Research

Published on 29 Aug 2024

Pulmonary miRNA expression after polytrauma depends on the surgical invasiveness and displays an anti-inflammatory pattern by the combined inhibition of C5 and CD14

in Cytokines and Soluble Mediators in Immunity

Nan Zhou
Rald V. M. Groven
Klemens Horst
Ümit Mert
Johannes Greven
Tom Eirik Mollnes
Markus Huber-Lang
Martijn van Griensven
Frank Hildebrand
Elizabeth R. Balmayor

Frontiers in Immunology

doi 10.3389/fimmu.2024.1402571

1,013 views

Perspective

Published on 29 Aug 2024

Extracellular Vesicles & Co.: scaring immune cells in the TME since ever

in Cytokines and Soluble Mediators in Immunity

Carlo Rodolfo
Silvia Campello

Frontiers in Immunology

doi 10.3389/fimmu.2024.1451003

891 views

Editorial

Published on 29 Aug 2024

Editorial: The chemokine system in epithelial immunity

in Cytokines and Soluble Mediators in Immunity

Géraldine Schlecht-Louf
Sara Federici
Bernhard Ryffel
Remo Castro Russo

Frontiers in Immunology

doi 10.3389/fimmu.2024.1481686

525 views

Mini Review

Published on 29 Aug 2024

Plasma concentrations of IL-6, MIP-1β, IP-10, and PTX-3 as predictors of the immunological response to antiretroviral treatment in people with HIV

in Cytokines and Soluble Mediators in Immunity

Marta Mejías-Trueba
Abraham Saborido-Alconchel
Ana Serna-Gallego
María Trujillo-Rodríguez
Esperanza Muñoz-Muela
Silvia Llaves-Flores
Nuria Espinosa
Cristina Roca-Oporto
Marta Herrero
Cesar Sotomayor

Frontiers in Immunology

doi 10.3389/fimmu.2024.1447926

998 views

Original Research

Published on 29 Aug 2024

TGF-β1 overexpression in severe COVID-19 survivors and its implications for early-phase fibrotic abnormalities and long-term functional impairment

in Cytokines and Soluble Mediators in Immunity

Enrique Alfaro
Raquel Casitas
Elena Díaz-García
Sara García-Tovar
Raúl Galera
María Torres-Vargas
María Fernández-Velilla
Cristina López-Fernández
José M. Añón
Manuel Quintana-Díaz

Frontiers in Immunology

doi 10.3389/fimmu.2024.1401015

808 views

Review

Published on 19 Aug 2024

Immunological and homeostatic pathways of alpha -1 antitrypsin: a new therapeutic potential

in Cytokines and Soluble Mediators in Immunity

Carmen Mazzuca
Laura Vitiello
Silvia Travaglini
Fatima Maurizi
Panaiotis Finamore
Simona Santangelo
Amelia Rigon
Marta Vadacca
Silvia Angeletti
Simone Scarlata

Frontiers in Immunology

doi 10.3389/fimmu.2024.1443297

1,397 views

Original Research

Published on 15 Aug 2024

IL-2 and TCR stimulation induce expression and secretion of IL-32β by human T cells

in Cytokines and Soluble Mediators in Immunity

Franziska Christine Sanna
Iva Benešová
Philip Pervan
Adriana Krenz
Alexander Wurzel
Robert Lohmayer
Jasmin Mühlbauer
Amélie Wöllner
Nina Köhl
Ayse Nur Menevse

Frontiers in Immunology

doi 10.3389/fimmu.2024.1437224

1,119 views

Opinion

Published on 14 Aug 2024

Tumor-produced immune regulatory factors as a therapeutic target in cancer treatment

in Cytokines and Soluble Mediators in Immunity

Vladimir Rogovskii

Frontiers in Immunology

doi 10.3389/fimmu.2024.1416458

1,145 views

Original Research

Published on 12 Aug 2024

The JAK1/JAK2 inhibitor ruxolitinib inhibits mediator release from human basophils and mast cells

in Cytokines and Soluble Mediators in Immunity

Remo Poto
Leonardo Cristinziano
Gjada Criscuolo
Caterina Strisciuglio
Francesco Palestra
Gianluca Lagnese
Antonio Di Salvatore
Gianni Marone
Giuseppe Spadaro
Stefania Loffredo

Frontiers in Immunology

doi 10.3389/fimmu.2024.1443704

1,587 views

Original Research

Published on 02 Aug 2024

Protection of stromal cell-derived factor-1 SDF-1/CXCL12 against proteases yields improved skin wound healing

in Cytokines and Soluble Mediators in Immunity

Rafaela Vaz Sousa Pereira
Mostafa EzEldeen
Estefania Ugarte-Berzal
Jennifer Vandooren
Erik Martens
Mieke Gouwy
Eva Ganseman
Jo Van Damme
Patrick Matthys
Jan Jeroen Vranckx

Frontiers in Immunology

doi 10.3389/fimmu.2024.1359497

995 views

Review

Published on 01 Aug 2024

Mast cell stabilizers: from pathogenic roles to targeting therapies

in Cytokines and Soluble Mediators in Immunity

Mengda Cao
Yao Gao

Frontiers in Immunology

doi 10.3389/fimmu.2024.1418897

2,992 views
1 citation

Correction

Published on 30 Jul 2024

Corrigendum: Modulation of natural killer cell exhaustion in the lungs: the key components from lung microenvironment and lung tumor microenvironment

in Cytokines and Soluble Mediators in Immunity

Hongxia Zhang
Jian Wang
Fengqi Li

Frontiers in Immunology

doi 10.3389/fimmu.2024.1467723

485 views

Original Research

Published on 25 Jul 2024

Interleukin-38 overexpression in keratinocytes limits desquamation but does not affect the global severity of imiquimod-induced skin inflammation in mice

in Cytokines and Soluble Mediators in Immunity

Arnaud Huard
Emiliana Rodriguez
Dominique Talabot-Ayer
Andreas Weigert
Gaby Palmer

Frontiers in Immunology

doi 10.3389/fimmu.2024.1387921

1,182 views

Review

Published on 24 Jul 2024

IL-2 based cancer immunotherapies: an evolving paradigm

in Cytokines and Soluble Mediators in Immunity

Sushama Rokade
Anita Mehta Damani
Martin Oft
Jan Emmerich

Frontiers in Immunology

doi 10.3389/fimmu.2024.1433989

4,271 views
1 citation

Navigation group

Articles

The role of cytokines in the pathogenesis of SAPHO syndrome

Rewiring the T cell-suppressive cytokine landscape of the tumor microenvironment: a new frontier for precision anti-cancer therapy

Pulmonary miRNA expression after polytrauma depends on the surgical invasiveness and displays an anti-inflammatory pattern by the combined inhibition of C5 and CD14

Extracellular Vesicles & Co.: scaring immune cells in the TME since ever

Editorial: The chemokine system in epithelial immunity

Plasma concentrations of IL-6, MIP-1β, IP-10, and PTX-3 as predictors of the immunological response to antiretroviral treatment in people with HIV

TGF-β1 overexpression in severe COVID-19 survivors and its implications for early-phase fibrotic abnormalities and long-term functional impairment

Immunological and homeostatic pathways of alpha -1 antitrypsin: a new therapeutic potential

IL-2 and TCR stimulation induce expression and secretion of IL-32β by human T cells

Tumor-produced immune regulatory factors as a therapeutic target in cancer treatment

The JAK1/JAK2 inhibitor ruxolitinib inhibits mediator release from human basophils and mast cells

Protection of stromal cell-derived factor-1 SDF-1/CXCL12 against proteases yields improved skin wound healing

Mast cell stabilizers: from pathogenic roles to targeting therapies

Corrigendum: Modulation of natural killer cell exhaustion in the lungs: the key components from lung microenvironment and lung tumor microenvironment

Interleukin-38 overexpression in keratinocytes limits desquamation but does not affect the global severity of imiquimod-induced skin inflammation in mice

IL-2 based cancer immunotherapies: an evolving paradigm